Found 6 matching trials
Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. PHASE3 This study will determine whether Synergo® RITE + MMC treatment is efficaci...
Show More Location
Chesapeake Urology Research Associates
Learn More & Join Trial
Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment N/A Bladder carcinoma is the most common malignancy of the urinary tract. Appro...
Show More Location
Meir Medical Center
Learn More & Join Trial
SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I PHASE3 A multi-institutional, prospective, randomised, open-label, superiority, co...
Show More Location
Multiple Locations
Learn More & Join Trial
Changes in Prostate Specific Antigen Levels During Synergo Therapy-Intravesical Chemotherapy Instillations Combined With Hyperthermia N/A PURPOSE: We determined whether Synergo therapy- intravesical chemotherapy i...
Show More Learn More & Join Trial
Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer PHASE3 The study is designed to compare the efficacy and safety of 2 treatment typ...
Show More Location
University Hospital - AKH Vienna
Learn More & Join Trial
RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE) PHASE3 This multicenter, prospective, single-arm, phase 3 study will assess the pr...
Show More Location
Multiple Locations
Learn More & Join Trial